Home / Therapies / DPP-4 Therapy Center (page 8)

DPP-4 Therapy Center

Practical Diabetes Care, 3rd Ed., Excerpt #1: Diabetes in the Emergency Department

alt

David Levy, MD, FRCP INTRODUCTION Every day many patients with established or newly diagnosed diabetes pass through emergency departments. Few require admission, but all need careful evaluation and management: emergencies in diabetes can develop rapidly, and they carry a risk of mortality. Deciding who needs admission requires clinical skill and experience. …

Read More »

Are DPP-4 Inhibitors Really a Risk Factor for Pneumonia?

An international team of researchers examined a cohort of nearly 50,000 patients to find out…. Dipeptidyl peptidase-4 (DPP-4) inhibitors may alter the immune response and increase the risk of infections, but evidence for this association is limited. The United Kingdom Clinical Practice Research Datalink (CPRD) and the Hospital Episodes Statistics …

Read More »

Early Insulin Therapy Makes an Impact

Improved glycemic control can reduce A1c, medical costs and complications… According to a new study, early introduction of insulin could save money, help more patients reach A1c goals and decrease diabetes-related complications and mortality. Currently, insulin therapy for persons with type 2 diabetes is traditionally added to an anti-hyperglycemic regimen …

Read More »

Diabetes Mellitus 101 for Cardiologists, Part 11

In this week’s Homerun Slides, we cover the importance of the Incretin Effect with an examination of the mechanisms of action of GLP-1 agonist and DPP-4 inhibitor drugs including the cardioprotective aspects of these medications…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 11 …

Read More »

The Efficacy of Saxagliptin in Combination Therapy

Saxagliptin shows improved glycemic control when added to other classes of medications in type 2 diabetes patients… Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by extending the half-life of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The medication can be used as monotherapy or in combination with …

Read More »

DPP-4 Inhibitors in Combination with Insulin Therapy for Type 2 Diabetes Patients

The addition of a DPP-4 inhibitor decreased HbA1C while not requiring an increase in insulin, and subjects remained weight neutral without experiencing an increase in hypoglycemic events… Currently approved dipeptidyl peptidase-4 (DPP-4) inhibitors include alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin. DPP-4 inhibitors work by enhancing glucose dependent insulin secretion and …

Read More »

Metformin Is Best Initial Oral Drug for Lowering Glucose Levels in Diabetes Patients

Metformin, sulfonylureas, thiazolidinedione, and DPP-4 inhibitors were compared to evaluate the effects on the time to subsequent treatment… There are many classes of oral drugs used for diabetes therapy, but there is a lack of evidence as to which drug is best for use as initial therapy. Most patients diagnosed …

Read More »